MediBeacon’s Breakthrough Device is Intended to Measure GFR in Patients with Impaired or Normal Kidney Function ST. LOUIS, Oct. 22, 2018 /PRNewswire/ — MediBeacon Inc., whose largest shareholder is Pansend Life […]
Read MoreCARDIALEN IS DEVELOPING A LOW-ENERGY IMPLANTABLE DEFIBRILLATION THERAPY DESIGNED TO MORE GENTLY RESTORE THE HEART TO A NORMAL RHYTHM. Minneapolis, Oct. 10, 2018 – Cardialen, Inc., a medical device company […]
Read MoreLargest Series C venture round raised by a St. Louis bioscience company Galera Therapeutics, Inc., a clinical-stage drug discovery company, whose research and development is based in St. Louis, today […]
Read MoreBioGenerator portfolio company Benson Hill Biosystems, a crop improvement company unlocking the natural genetic diversity of plants, today announced the first close of its $60 million Series C financing. BioGenerator was […]
Read MoreBioAcquisition expands Mediware’s solutions to include software for skilled nursing and assisted living facilities and offers BlueStrata EHR expanded resources for investments in innovation and sales. Mediware Information Systems, Inc., […]
Read MoreFollowing Pfizer’s announcement to cut 600 of its 1,000 St. Louis-area jobs in 2009, several Pfizer executives, including Joe Monahan and Walter Smith, faced a difficult decision. They could relocate […]
Read MoreStartup to Advance Research Tools Development and Add Jobs ST. LOUIS – Canopy Biosciences has exceeded its Series A financing goal, closing a $2.4 million investment to develop new research […]
Read MoreSt. Louis, May 14, 2018 – BacterioScan, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a 510(k) Premarket Notification clearance for its 216Dx Urinary Tract […]
Read MoreBioGenerator-backed AgTech Company Focuses on Naturally-Occurring Process ST. LOUIS – RNAgri, a St. Louis startup developing technology for agriculture, has entered a research collaboration with global agriculture company Monsanto. The […]
Read MoreBioGenerator-supported Company to Advance Cancer Therapies ST. LOUIS – St. Louis-based startup Unleash Immuno Oncolytics, which has developed viral-based biologics to attack cancerous tumors, has attracted a major investment from […]
Read More